---
title: "PRCT.US (PRCT.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PRCT.US/news.md"
symbol: "PRCT.US"
name: "PRCT.US"
parent: "https://longbridge.com/en/quote/PRCT.US.md"
datetime: "2026-05-21T21:41:51.286Z"
locales:
  - [en](https://longbridge.com/en/quote/PRCT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PRCT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PRCT.US/news.md)
---

# PRCT.US (PRCT.US) — Related News

### [A Look At PROCEPT BioRobotics (PRCT) Valuation As AUA Guideline Update Expands Aquablation Opportunity](https://longbridge.com/en/news/286654084.md)
*2026-05-16T22:08:05.000Z*
> PROCEPT BioRobotics (PRCT) gains attention as updated AUA guidelines boost support for its Aquablation therapy. Despite 

### [PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen](https://longbridge.com/en/news/286444153.md)
*2026-05-14T15:35:58.000Z*
> TD Cowen analyst Josh Jennings has reiterated a Buy rating on PROCEPT BioRobotics (PRCT) with a price target of $34.00. 

### [PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.4%  - Should You Buy?](https://longbridge.com/en/news/286142589.md)
*2026-05-12T18:33:24.000Z*
> Shares of PROCEPT BioRobotics (NASDAQ:PRCT) rose 7.4% to $28.41 on Tuesday, with a trading volume of 588,266 shares. Ana

### [PROCEPT BioRobotics Corporation $PRCT Shares Sold by Comerica Bank](https://longbridge.com/en/news/286055323.md)
*2026-05-12T07:42:25.000Z*
> Comerica Bank has significantly reduced its stake in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) by 95.5%, now holding

### [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://longbridge.com/en/news/284769168.md)
*2026-04-30T12:06:00.000Z*
> In Thursday's pre-market session, Akanda (NASDAQ:AKAN) saw a significant gain of 21.7%, reaching $31.64, while Glaukos (

### [PROCEPT Posts Strong Q1 Growth, Driven By U.S. System Sales And Procedure Expansion](https://longbridge.com/en/news/284731460.md)
*2026-04-30T09:05:14.000Z*
> PROCEPT BioRobotics Corporation (PRCT) reported strong Q1 2026 results with revenue of $83.1 million, a 20% increase fro

### [PROCEPT BioRobotics Q1 Earnings Call Highlights](https://longbridge.com/en/news/284664453.md)
*2026-04-30T00:27:27.000Z*
> PROCEPT BioRobotics (NASDAQ:PRCT) reported Q1 2026 revenue of $83.1 million, a 20% increase year-over-year. CEO Larry Wo

### [](https://longbridge.com/en/news/284642991.md)
*2026-04-29T20:52:02.000Z*
> PROCEPT BioRobotics shares are trading higher after the company reported better-than-expected Q1 sales results and reaff